ホーチミン カジノ History
-
1949 Established カジノシークレット with ¥200 million capital. Developed polyvinyl chloride (PVC), KANEVINYL™. 1950 Started first mass production of PVC, KANEVINYL™, in Japan. Started first production of PVC wire covering. 1952 Developed and marketed solution-type PVC, KANEVILACK™. 1953 Started large scale production of margarine and shortening. Started production of flexible PVC compounds, KANEVINYL™ Compound. 1957 Developed and marketed KANECARON™. 1958 Awarded Deming Application Prize. -
1960 Takasago Manufacturing Site KANEVINYL™ facilities was completed and production began. 1961 Developed and marketed BELCO™. 1964 Developed and marketed KANEACE™ B. 1965 Developed and marketed expandable polystyrene, KANEPEARL™. Started sales of Kanekalon wig, Fontaine. 1966 Started first production of rigid PVC compounds, KANEVINYL™ Compound. Developed and marketed heat resistant ABS resin, ホーチミン カジノ MUH (Transferred in 2001). 1967 Developed a PVC paste, which began production and sales as KANEVINYL™ Paste. 1968 Established Europe office and New York office. Developed and marketed chlorinated PVC. Completed vinyl chloride monomer plant using oxychlorination process. -
1970 Developed and marketed extruded polystyrene foam board, KANELITEFOAM™. Established ホーチミン カジノ Belgium N.V. 1971 Completed KANEPEARL™ plant. Established ホーチミン カジノ America Corporation. 1972 Developed and marketed self-extinguishing ABS resin, Enplex. 1973 Received prize from the Society of Polymer Science of Japan for KANEACE™ B resin manufacturing technology. Developed and marketed polyethylene foam using bead method, EPERAN™. Developed and marketed bonded magnet, ホーチミン カジノ FLUX™. Completed plant for KANEACE™ B at ホーチミン カジノ Belgium N.V. 1974 Developed Glutathione, pharmaceutical intermediate for hepatic medicines, using fermentation, and started production. 1977 Developed and marketed Ubidecarenone, pharmaceutical bulk for cardiac medicines. 1978 Developed and marketed weather-resistant MMA resin-based film, SUNDUREN™. 1979 Established ホーチミン カジノ Singapore Co. (Pte.) Ltd. Developed and marketed Silyl terminated polyethers, ホーチミン カジノ MS POLYMER™. -
1980 Marketed pharmaceutical intermediates, HPG. 1981 Received prize from the Society of Polymer Science of Japan for ホーチミン カジノ MS POLYMER™. 1982 Marketed PVC sash window, Excel Window. Received award from the Chemical Society of Japan for the technical development of D-para-hydroxyphenylglycine manufacturing technology. Established ホーチミン カジノ Texas Corporation (now ホーチミン カジノ North America LLC). 1983 Received a “Nikkei Superior Product and Service Award” for Kanekalon’s artificial fur from the Nikkei Marketing Journal. Developed and marketed AMMPA ホーチミン カジノ, intermediate for anti-hypertensive medicine. Developed and marketed acrylic silicon polymer, ホーチミン カジノ GEMLAC™. 1984 Received award from the Society of Fiber Science and Technology, Japan for flame retardant fiber technology. Developed and marketed amorphous photovoltaic modules. Developed and marketed polyimide film, APICAL™. Completed plant for KANEACE™ B at ホーチミン カジノ Texas. 1985 Developed and marketed polypropylene foam using bead method, EPERAN-PP™. Completed plant for EPERAN™ at ホーチミン カジノ Belgium N.V. 1986 Commercialized blood purification system and commenced production and sale of the SULFLUX membrane-type plasma separator and the LIPOSORBER™ low-density lipoprotein(LDL) absorber. Received prize from the Society of Fermentation Technology, Japan for β-hydroxy fatty acid. 1987 Established ホーチミン カジノ Germany(now ホーチミン カジノ Medical Europe N.V.). Received prize from the Society of Fiber Science and Technology, Japan for Kanekalon coloring and spinning method. 1988 Received Inoue Harushige Award from the Research Development Corporation of Japan for amorphous photovoltaic modules research and commercialization. 1989 Established Allied-Apical Co. (now ホーチミン カジノ North America LLC). Received award from the Society of Polymer Science of Japan for plasmapheresis system. Developed modified PET resin, ホーチミン カジノ HYPERITE™. -
1990 Started production of EPERAN™ and EPERAN-PP™ at ホーチミン カジノ Texas. Started production of APICAL™ at Allied-Apical Co. 1991 Developed and marketed Selesorb™, a selective adsorption column for systemic lupus erythematosus. 1992 Received award from the Japan Institute of Invention and Innovation for ホーチミン カジノ MS POLYMER™. Established ホーチミン カジノ Technical Service Co., Ltd. Shanghai. 1993 Established Nantong Sunrise Worsted Spinning Co., Ltd. as a joint venture with Kyusyu Kanekalon Co., Ltd. Kanematsu Corporation, and Toyobo Co., Ltd. Received award from the Kinki Chemical Society, Japan, for APICAL™ NPI. Received award from the Society of Fiber Science and Technology, Japan, for Protex™, a flame retardant fiber. 1994 Manufacturing approval obtained for Lixelle™ plasma purification device for use in the treatment of dialysis-related amyloidosis. Established ホーチミン カジノ Pharma Europe N.V.(now ホーチミン カジノ Medical Europe N.V.). 1995 Marketed transparent film, ELMECH™. Established ホーチミン カジノ (Malaysia) Sdn. Bhd. 1996 Established ホーチミン カジノ Delaware Corporation. Established ホーチミン カジノ Plastics Corporation. Established ホーチミン カジノ Eperan Sdn. Bhd. 1997 Established ホーチミン カジノ Pharma America LLC(now ホーチミン カジノ Medical America LLC). ホーチミン カジノ Malaysia began production of EPERAN™ and MBS resin. Established ホーチミン カジノ High-Tech Materials (now ホーチミン カジノ north America) to carry on the business operations of Allied-Apical. Kashima Manufacturing Site production facilities completed for EPION™ liquid polyisobutylene resin. ホーチミン カジノ Belgium began production of ホーチミン カジノ MS POLYMER™. 1998 Established ホーチミン カジノ Consulting (Shanghai) Co., Ltd. (now ホーチミン カジノ Trading (Shanghai) Co., Ltd.). 1999 Established ホーチミン カジノ Paste Polymers Sdn. Bhd. -
2000 Completed new Eperan factory in Michigan for ホーチミン カジノ Texas Corporation. Acquired ISO 14001 registration at four plants in Japan. Attained ISO 9001 certification for all related company divisions (an industry first) involved in making KANELITEFOAM™. Started domestic sales of photovoltaic solar power generation system. Constructed life sciences research divisions. Developed word’s first non-fluorocarbon, non-halogen foaming agent KANELITEFOAM™, JIS category 3 insulation panel. 2002 Began to sell the functional food material ホーチミン カジノ Coenzyme Q10. Began to sell large-area see-through type photovoltaic modules. Began to sell nation’s first embolization coil. 2003 Established HiHua Fiber Co., Ltd in China. Established Suzhou Eperan Plastic Ltd. (now ホーチミン カジノ Eperan (Suzhou) Co., Ltd.). Developed an imide film capable of forming a three-dimensional optical waveguide with a laser. 2005 Developed an industry’s first Acryl grafted-Vinyl Chloride copolymer, PRICTMER™. 2006 Industrialized world’s first Telechelic polyacrylate. Developed a new injection molding resin by applying proprietary nanocomposite technology. Developed toughness-enhancing master batches for epoxy resin. 2007 Established ホーチミン カジノ Pharma Vietnam Co., Ltd. (now ホーチミン カジノ Medical Vietnam Co., Ltd.) and KSS Vietnam Co., Ltd. 2008 Achieved Zero-emission status at all production facilities in Japan for the second straight year. Developed transparent curable resin with heat and light resistance ILLUMIKA™. Developed world’s most advanced high thermal conductive graphite sheet, Graphinity™. Began commercial production of the isobutylene thermoplastic elastomer SIBSTAR™. 2009 Established Photovoltaic & Thin Film Device Research Laboratories. Established Solar Cell Research Division in ホーチミン カジノ Belgium. Established KM Transderm Ltd. -
2010 Developed new thermally conductive plastics with electric insulating properties. Established ホーチミン カジノ India Pvt. Ltd. Formed a capital alliance with Belgian biotechnology firm, Eurogentec S.A.(now ホーチミン カジノ Eurogentec S.A.). Rolled out Organic EL Lighting Panels Business. Established GeneFrontier Corporation. Established ホーチミン カジノ Innovative Fibers Sdn. Bhd. 2011 Developed world’s first completely bio-based polymer with soft and heat-resistant properties Received prize from the Society of Polymer Science of Japan for Telechelic polyacrylate. Established ホーチミン カジノ Modifiers Deutschland GmbH. Established ホーチミン カジノ Taiwan Corporation. Established ホーチミン カジノ Korea Corporation. Established ホーチミン カジノ (Foshan) High Performance Materials Co., Ltd. Received prize from the 21st International Photovoltaic Science and Engineering Conference. 2012 Established ホーチミン カジノ Asia Co., Ltd., an Asia regional holding company based in Shanghai, China. Established ホーチミン カジノ Americas Holding, Inc., an Americas regional holding company based in Texas, USA. Began to sell ホーチミン カジノ KanCapA™ selected by global pharmaceutical companies. Established ホーチミン カジノ Apical Malaysia Sdn. Bhd. 2013 Established ホーチミン カジノ South America Representative Ltd. in Brazil. Established PT. ホーチミン カジノ Foods Indonesia. Established ホーチミン カジノ US Material Research Center Facility within Texas A&M. 2014 Commenced sale of organic EL lighting panels with the world’s longest service life and excellent color stability. Developed Ikazuchi Zero catheter and commenced sale of this product for use in percutaneous coronary arterioplasty. 2015 Signed the United Nations Global Compact, a concept advocated by former UN Secretary-General. ホーチミン カジノ Europe Holding company N.V. was established to accelerate business expansion in Europe, the Middle East and Africa(EMEA). ホーチミン カジノ MS Malaysia Sdn. Bhd., a new ホーチミン カジノ MS POLYMER™ production plant, was established. A research facility specializing in regenerative medicine and cell therapy was established in Kobe. Established ホーチミン カジノ (Thailand) Co., Ltd. 2016 Acquired a shareholding in Cemedine Co., Ltd., which became a consolidated subsidiary. Opened ホーチミン カジノ Africa Liaison office in Ghana to accelerate business development in Africa. Established ホーチミン カジノ US Innovation Center. Achieved the world's highest conversion efficiency in a crystalline silicon solar cell module. 2017 Established ホーチミン カジノ Hokkaido Co., Ltd. Acquired a US formulated advanced resin supplier (ホーチミン カジノ Aerospace LLC). Initiated clinical research on regenerative medicine of alveolar bones using ホーチミン カジノ’s closed-circuit cell culture system. Granted the certificate of biodegradability in marine environment for biodegradable plastics . Concluded license contract with European company and entered the drug-coated balloon business. 2018 ホーチミン カジノ Aerospace acquired the composites portfolio of Henkel Corporation. Acquired a patent for large scale culturing pluripotent stem cells in Japan. Developed genome editing technology jointly with NARO, enabling short term breeding in wheat. Entered the dairy products business. Invested in AB-Biotics S.A., a Spanish biotech company and concluded a license agreement for production and sales of its probiotics products. Started to sell fermented butter in Japan. Adopted for JICA’s collaboration program with the private sector for disseminating Japanese technology in Kenya. 2019 Decided to Set Up New Processed Oil Products Factory in Indonesia. Increased Production Capacity of Modifiers for Epoxy Resins. Started production of EPERAN™ and EPERAN-PP™ at ホーチミン カジノ (Thailand) Co., Ltd. Developed Super Heat-Resistant Polyimide Film for 5G Applications. Launched Belgian Yogurt Pur Natur. Began trial introduction of Seven Café straws made with ホーチミン カジノ Biodegradable Polymer. ホーチミン カジノ Biodegradable Polymer was listed in the Plastic Implement Measure of the European Commission for all food types. Received the 3rd Japan Bioindustry Award. Began to sell a new coil for embolization of brain aneurysms. Completed ホーチミン カジノ Biodegradable Polymer Green Planet™ Plant with annual production of 5,000 tons. Developed an exterior system that generates electricity by the outer wall and window surfaces of buildings, T-Green Multi Solar*.*T-Green is a registered trademark of Taisei Corporation. -
2020 ホーチミン カジノ’s see-through photovoltaic modules were adopted in the Japan National Stadium. Signed an agreement with Japan Tobacco Inc. to acquire assets related to plant biotechnology. Developed ultra-heat-resistant polyimide film for 5G millimeter wave zones. 2021 Began to sell Watashi no Chikara (My Energy)™ - Q10 yogurt. Began to sell PCR test kit for COVID-19 variants. Opened Panmusubi, a mall-type EC site that enables customers to directly buy bread from famous bakeries nationwide. Signed official partnership agreement with Kashima Antlers. 2022 Cemedine Co., Ltd. became a wholly owned subsidiary. Completed a new plant for medical equipment in ホーチミン カジノ Medical Vietnam Co., Ltd. Developed T-Green Multi Solar* for balconies with Taisei Corporation.*T-Green is a registered trademark of Taisei Corporation. Started to manufacture and supply intermediates for Shionogi COVID-19 drug. 2023 Development of Polymer Synthesis Technology by microorganisms using CO2 as direct raw material was selected as a NEDO Green Innovation Fund Project. Belgian chocolate brand BENOIT NIHANT opened its fragship store. Japan Medical Device Technology Co., Ltd. became a wholly owned subsidiary. 2024 Opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido.